loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2002_027___rev_06 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Dr. Reddy's Laboratories

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    Key Products KEY PRODUCTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 DR. REDDY'S LABORATORIES LIMITED Hyderabad IN (1)

    filter

    01 Nizatidine (1)

    filter

    01 India (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    DR. REDDY'S LABORATORIES LIMITED Hy...

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Nizatidine

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2002-027 - Rev 06
    Valid
    Chemical
    2023-04-24
    1453
    Dr Reddy Company Banner

    CPhI North America

    Attending

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2002-027 - Rev 06 of Dr. Reddy's Laboratories Limited Hyderabad In

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2002-027 - Rev 06 of Dr. Reddy's Laboratories Limited Hyderabad In 1

    20

    Dr. Reddy's Laboratories Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    One of their significant offerings is Nizatidine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2002-027 - Rev 06

    This Chemical Type CEP, issued on April 24, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1453 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY